Literature DB >> 22890417

hsa-miR-503 is downregulated in β thalassemia major.

Papai Roy1, Gargi Bhattacharya, Ansuman Lahiri, Uma B Dasgupta, Debasis Banerjee, Sarmila Chandra, Manikanchan Das.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22890417     DOI： 10.1159/000339492

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  4 in total

Review 1.  Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.

Authors:  Henu Kumar Verma; Yashwant Kumar Ratre; L V K S Bhaskar; Raffaella Colombatti
Journal:  Ann Hematol       Date:  2021-01-04       Impact factor: 3.673

Review 2.  MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin.

Authors:  Najmaldin Saki; Saeid Abroun; Masoud Soleimani; Maria Kavianpour; Mohammad Shahjahani; Javad Mohammadi-Asl; Saeideh Hajizamani
Journal:  Cell J       Date:  2016-01-17       Impact factor: 2.479

3.  Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia.

Authors:  Haiwei Wang; Meihuan Chen; Shiyi Xu; Yali Pan; Yanhong Zhang; Hailong Huang; Liangpu Xu
Journal:  J Clin Lab Anal       Date:  2021-08-16       Impact factor: 2.352

4.  MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Authors:  Fenqiang Xiao; Wu Zhang; Liming Chen; Fei Chen; Haiyang Xie; Chunyang Xing; Xiaobo Yu; Songming Ding; Kangjie Chen; Haijun Guo; Jun Cheng; Shusen Zheng; Lin Zhou
Journal:  J Transl Med       Date:  2013-08-22       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.